Regulation of miR-146a by RelA/NFkB and p53 in STHdh q111/Hdh q111 cells, a cell model of Huntington's disease

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ghose, Jayeeta ^a   Sinha, Mithun ^a   Das, Eashita ^a   Jana, Nihar R ^b   Bhattacharyya, Nitai P ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

^b NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; MICRORNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 150; PROTEIN HYPK; PROTEIN P53; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; HD PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIRN125 MICRORNA, HUMAN; MIRN146 MICRORNA, HUMAN; MIRN150 MICRORNA, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; RELA PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUNTINGTON CHOREA; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; TUMOR CELL CULTURE;

MUS;

GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; MICRORNAS; NERVE TISSUE PROTEINS; NF-KAPPA B; NUCLEAR PROTEINS; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052041448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023837     Document Type: Article

References (72)

1. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, et al. (2008) Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412: 191-209.
2. Cha JH, (2007) Transcriptional signatures in Huntington's disease. Prog Neurobiol 83: 228-48.
3. Sugars KL, Rubinsztein DC, (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19: 233-238.
4. Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, et al. (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47: 29-41.
5. Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, et al. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238-2243.
6. Takano H, Gusella JF, (2002) The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor. BMC Neuroscience 14: 3-15.
7. Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291: 2423-2428.
8. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, et al. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci 97: 6763-6768.
9. Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, et al. (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 24: 217-233.
10. Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, et al. (2006) p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25: 1-7.
11. Ryan AB, Zeitlin SO, Scrable H, (2006) Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis. Neurobiol Dis 24: 419-427.
12. Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH, et al. (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci 24: 7999-8008.
13. Goswami A, Dikshit P, Mishra A, Mulherkar S, Nukina N, et al. (2006) Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. Biochem Biophys Res Commun 342: 184-190.
14. Godavarthi SK, Narender D, Mishra A, Goswami A, Rao SN, et al. (2009) Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction. J Neurochem 108: 787-795.
15. Liu J, (2008) Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol 20: 214-221.
16. Ørom UA, Nielsen FC, Lund AH, (2008) MicroRNA-10a binds the 5′ UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30: 460-471.
17. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R, (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci 105: 1608-1613.
18. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
19. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
20. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, et al. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
21. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, et al. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci 102: 16426-16431.
22. Hermeking H, (2007) p53 enters the microRNA world. Cancer Cell 12: 414-418.
23. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
24. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
25. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, et al. (2009) Modulation of microRNA processing by p53. Nature 460: 529-533.
26. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593.
27. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
28. Le MTN, The C, Shyh-Chang N, Xie H, Zhou B, et al. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23: 862-876.
29. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci 103: 12481-12486.
30. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, et al. (2008) A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 29: 438-445.
31. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL, (2008) The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 28: 14341-14346.
32. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, et al. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9: 2799-2809.
33. Sinha M, Ghose J, Das E, Bhattarcharyya NP, (2010) Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP. Biochem Biophys Res Commun 396: 742-747.
34. Chakravorty M, Datta De D, Choudhury A, Roychoudhury S, (2009) IL1B promoter polymorphism regulates the expression of gastric acid stimulating hormone gastrin. Int J Biochem Cell Biol 41: 1502-1510.
35. Kopp E, Ghosh S, (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959.
36. Griffiths-Jones S, (2004) The MicroRNA Registry. Nucl Acids Res 32 (Database Issue): D109-D11155.
37. Kawauchi K, Araki K, Tobiume K, Tanaka N, (2008) Activated p53 induces NFkappaB DNA binding but suppresses its transcriptional activation. Biochem Biophys Res Commun 372: 137-141.
38. Wadgaonkar R, Phelps KM, Haque Z, Williams AJ, Silverman ES, et al. (1999) CREB-binding protein is a nuclear integrator of nuclear factor-κB and p53 signaling. J Biol Chem 274: 1879-1882.
39. Webster GA, Perkins ND, (1999) Transcriptional cross talk between NF-kB and p53. Mol Cell Biol 19: 3485-3495.
40. Huang WC, Ju TK, Hung MC, Chen CC, (2007) Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 26: 75-87.
41. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC, (2004) p53 induces NF- kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 279: 26115-26125.
42. Ryan KM, Ernst MK, Rice NR, Vousden KH, (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404: 892-897.
43. Xiao-Xin S, Mu-Shui D, Hua L, (2007) 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction. J Biol Chem 282: 8052-8059.
44. Majumder P, Raychaudhuri S, Chattopadhyay B, Bhattacharyya NP, (2007) Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range. Cell Mol Neurobiol 27: 1127-1145.
45. Raychaudhuri S, Sinha M, Mukhopadhyay D, Bhattacharyya NP, (2008) HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity. Hum Mol Genet 17: 240-255.
46. Kaznacheeva AV, Guzhova IV, Margulis BA, (2009) Protective Effect of Hsp70 Molecular Chaperone in Polyglutamine Diseases Is Realized by Sequestering of GAPDH. Biologicheskie Membrany 26: 314.
47. Mangarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice. Cell 87: 493-506.
48. Lee ST, Chu K, Im WS, Yoon HJ, Im JY, et al. (2010) Altered microRNA regulation in Huntington's disease models. Exp Neurol 227 (1): 172-179.
49. Lukiw WJ, Zhao Y, Cui JG, (2008) An NF-kB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer's Disease and in Stressed Human Brain Cells. J of Biol Chem 283: 31315-31322.
50. Hill JM, Zhao Y, Clement C, Neumann DM, Lukiw WJ, (2009) HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory Signalling. Neuroreport 20 (16): 1500-1505.
51. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijiling J, et al. (2010) Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 31 (6): 1100-7.
52. Saba R, Goodman CD, Huzarewich LCH, Robertson C, Booth SA, (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3 (11): e3652.
53. Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R, (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517.
54. Beg AA, Baltimore D, (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784.
55. Bertrand F, Atfi A, Cadoret A, L'Allemain G, Robin H, et al. (1998) A role for nuclear factor kappaB in the antiapoptotic function of insulin. J Biol Chem 273: 2931-2938.
56. Royds JA, Dower SK, Qwarnstrom EE, Lewis CE, (1998) Response of tumour cells to hypoxia: role of p53 and NFkB. Mol Pathol 51: 55-61.
57. Gines S, Ivanova E, Seong IS, Saura CA, MacDonald ME, (2003) Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J Biol Chem 278: 50514-50522.
58. Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, et al. (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum Mol Genet 12: 497-508.
59. Lee JM, Ivanova EV, Seong IS, Cashorali T, Kohane I, et al. (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLoS Genet 3 (8): e135.
60. Benn CL, SunT, Sadri-Vakili G, McFarland KN, DiRocco DP, et al. (2008) Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 28: 10720-10733.
61. Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson G, (2008) Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. J Biol Chem 283: 25628-25637.
62. Xifró X, García-Martínez JM, Del Toro D, Alberch J, Pérez-Navarro E, (2008) Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells. J Neurochem 105: 596-612.
63. Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, et al. (2009) Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line. Neurol Res 31: 77-83.
64. Subramaniam S, Sixt KM, Barrow R, Snyder SH, (2009) Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity. Science 324: 1327-1330.
65. Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, et al. (2005) Clostridium difficile Toxin A-Induced Colonocyte Apoptosis Involves p53-Dependent p21(WAF1/CIP1) Induction via p38 Mitogen-Activated Protein Kinase. Gastroenterology 129: 1875-1888.
66. Stanta G, Schneider C, (1991) RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification. Biotechniques 11 (3): 304-308.
67. Stanta G, Bonin S, Perin R, (1998) RNA Extraction from Formalin-Fixed and Paraffin-Embedded Tissues. Methods in Molecular Biology 86: 23-26.
68. Korbler T, Grskovic M, Dominis M, Antica M, (2003) A simple method for RNA isolation from formalin-fixed and paraffin-embedded lymphatic tisuues. Experimental and Molecular Pathology 74: 336-340.
69. Li J, Smyth P, Flavin R, Cahill S, Denning K, et al. (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 29: 7-36.
70. Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, et al. (2008) Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 10 (3): 203-211.
71. Liu A, Xu X, (2011) MicroRNA Isolation from Formalin-Fixed, Paraffin-Embedded Tissues. Methods Mol Biol 724: 259-67.
72. Peltier HJ, Latham GJ, (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.